C12N 2740/10033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2740/10033 (Use of viral protein as therapeutic agent other than vaccine) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 8
- Inventors
- 19
- Latest grant
- 28 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 3 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- Apoptotic upregulation by myxoma virus expressing walleye dermal sarcoma virus orfC28 Feb 2023US 11,591,616 B1Colorado State University Research Foundation
- Immunostimulating peptides27 Jul 2021US 11,072,638 B2Aimvion A/S
- Compositions and methods involving endogenous retrovirus proteins30 Jan 2018US 9,878,002 B2Regents of the University of Minnesota
- Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas Fusion Protein and Methods of Treatment6 Jun 2024US 2024/0181084 A1University of Rochester
- Non-naturally occurring capsids for delivery of nucleic acids and/or proteins8 Dec 2022US 2022/0389062 A1Massachusetts Institute of Technology
- Non-naturally occurring capsids for delivery of nucleic acids and/or proteins5 Nov 2020US 2020/0347100 A1Massachusetts Institute of Technology
- Novel immunostimulating peptides27 Jun 2019US 2019/0194278 A1Aimvion A/S
- Messenger rna based viral production2 May 2019US 2019/0127708 A1Translate Bio, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.